Vascular Imaging Market – Trends Forecast Till 2030

Market Snapshot

Market Overview

The global Vascular Imaging market size was estimated at USD 6.4 billion in 2023 and is projected to reach USD 12.4 billion in 2030 at a CAGR of 9.8% during the forecast period 2023-2030.

Vascular imaging, a medical diagnostic modality, plays a pivotal role in the identification and characterization of various cardiovascular diseases by employing the imaging of the vascular tissues. The technique primarily utilizes ultrasound, an imaging modality that employs high-frequency sound waves, to assess the blood flow, blood pressure, circulation, and the oxygen saturation levels in the blood within the veins and arteries. Additionally, other techniques, such as computerized tomography angiography, fluoroscopy (a technique that involves moving X-ray images using contrast dye), magnetic resonance angiography, and X-ray angiography, also find applicability in vascular imaging, thereby enhancing the diagnostic accuracy and reliability of the procedure.

The growth in the population of the elderly, which is characterized by a significant increase in life expectancy, coupled with the progressive technological advancements in vascular imaging devices, has led to an upsurge in the incidence of cardiovascular diseases. Consequently, there has been an increase in the demand for minimally invasive diagnostic and therapeutic interventions, owing to the favorable outcomes they offer. Nevertheless, the high cost of vascular imaging instruments and the availability of conventional treatment alternatives have impeded the growth of the market. Despite these challenges, emerging economies and the increasing number of diagnostic imaging centers have presented viable opportunities for market growth.

The pandemic caused by the novel coronavirus disease (COVID-19) has had a significant impact on all imaging practices throughout the nation. In addition to the effects of COVID-19, various policy measures implemented to impede disease transmission have resulted in a reduction in the demand for imaging. Furthermore, hospitals are taking steps to increase their crisis capacity, which in turn has led to a decrease in the amount of medically appropriate imaging procedures being undertaken. Although economic recessions typically lead to a reduction in healthcare expenditures, imaging groups have never before experienced an economic shock that has been compounded by the need to limit the availability of imaging. These changes will have a profound impact on outpatient practices, with the volume of imaging procedures expected to decline.

Delvens Industry Expert's Standpoint

The anticipated increase in the elderly population is expected to act as a driving force for the growth of the vascular imaging market. Additionally, the estimated advancements in the technological aspects of vascular imaging devices are predicted to act as a supporting factor for the growth of the vascular imaging market. Conversely, the availability of traditional treatment alternatives is expected to hinder the growth of the vascular imaging market during the stipulated period.

Furthermore, the countries that are progressing rapidly as potential areas of growth, the rising number of diagnostic imaging centers, and the increasing acceptance of restored vascular imaging systems are expected to provide further opportunities for the growth of the vascular imaging market in the upcoming years. Nonetheless, the scarcity of medical physicists, the presence of smaller players, and entry barriers for new entrants are likely to pose challenges to the growth of the vascular imaging market in the foreseeable future.

Market Portfolio

Key Findings

• On the basis of technique, This market is segmented into different techniques, which are different ways of imaging the blood vessels. Magnetic resonance imaging (MRI) is a technique that uses a strong magnetic field and radio waves to create detailed images of the blood vessels and surrounding tissues. It is non-invasive and does not use ionizing radiation. Ultrasound is a technique that uses high-frequency sound waves to create images of the blood vessels. It is non-invasive and does not use ionizing radiation. Computed tomography (CT) is a technique that uses X-rays and computer processing to create detailed images of the blood vessels and surrounding tissues. It is non-invasive but does use ionizing radiation. Nuclear imaging is a technique that uses small amounts of radioactive material to create images of the blood vessels and surrounding tissues. It can be used to diagnose and treat certain conditions. It does use ionizing radiation.

• On the basis of procedure, This market is segmented into different categories based on the specific techniques used to perform the imaging. One of these categories is coronary angiography, which is a technique used to visualize the blood vessels in the heart. Another category is peripheral angiography, which is used to visualize the blood vessels in the arms and legs. Neurovascular angiography is a technique used to visualize the blood vessels in the brain and spinal cord. Vascular ultrasound procedures use sound waves to visualize the blood vessels and are often used to diagnose conditions like deep vein thrombosis. Micro angiography is a technique that uses a contrast agent and X-rays to visualize the smallest blood vessels in the body.

• On the basis of application, This segment is further divided into two categories: diagnostic applications and therapeutic applications. Diagnostic applications refer to the use of vascular imaging techniques for the purpose of diagnosis, such as identifying blockages or narrowing of blood vessels, detecting blood clots, or assessing the overall health of the blood vessels. Therapeutic applications, on the other hand, refer to the use of vascular imaging techniques for the purpose of treatment, such as guiding the placement of stents or catheters, or monitoring the progress of a treatment. The segmentation of the vascular imaging market into diagnostic and therapeutic applications is important because it helps to identify the different ways in which these imaging techniques are used in clinical practice.
   
• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is currently occupying a dominant position in the vascular imaging market owing to the presence of several major players in the field. Moreover, the market is expected to witness a remarkable growth trajectory in the aforementioned region during the forecast period, and this growth can be attributed to the implementation of streamlined regulations regarding repayment as well as the escalating incidence of stroke cases.

Regional Analysis

North America to Dominate the Market

• North America dominates the vascular imaging market due to the occurrence of major players. Furthermore, the streamlined repayment regulations and growing of the incidence of stroke will further boost the growth of the vascular imaging market in the region during the forecast period.
   
• Asia-Pacific is projected to observe significant amount of growth in the coming years due to rise in the incidence of cardiovascular disorders in the region.

Competitive Landscape

• Swedish Medical Centre
• Brigham and Women's Hospital
• Toshiba Corporation,
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Shimadzu Corporation
• Samsung Medison Co., Ltd.
• Abbott
• Hologic, Inc.
• FUJIFILM Corporation
• ESAOTE SPA
• Carestream Health.
• Terumo Corporation
• KONICA MINOLTA INC.
• Pie Medical Imaging B.V.
• Alpinion Medical Systems Co. Ltd.
• CorVascular Diagnostics LLC
• LUMEDX
• Stryker Corporation
• BK Medical Holding Company, Inc.

Recent Developments

• In November 2022, At RSNA 2022, Philips unveiled a new, portable ultrasound equipment that will enable more patients to receive accurate diagnoses for the first time. The New Ultrasound compact system 5000 series provides superior image quality in a small device, assisting in a confident diagnosis.
   
• In July 2022, Philips announced it was acquiring Carestream health, a provider of imaging systems, for 2.2 billion USD. this acquisition will strengthen philips position in the medical imaging technology sector, as Carestream Health is a global leader in medical imaging and IT solutions.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
   
• Gain authentic and granular data access for the Vascular Imaging Market to understand the trends and the factors involved in changing market situations.
   
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
   
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope